These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26340849)

  • 41. Re: Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    O'Croinin F; Zibin T
    J Psychiatry Neurosci; 1994 May; 19(3):226. PubMed ID: 8031748
    [No Abstract]   [Full Text] [Related]  

  • 42. Long-term changes in AIMS ratings and their relation to medication history [proceedings].
    Smith JM; Burke MP; Moon CO
    Psychopharmacol Bull; 1981 Jan; 17(1):120-1. PubMed ID: 7232640
    [No Abstract]   [Full Text] [Related]  

  • 43. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
    Singh MM
    Dis Nerv Syst; 1976 Apr; 37(4):191-6. PubMed ID: 767080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dermoscopic and reflectance confocal microscopic features of exogenous ochronosis.
    Gil I; Segura S; Martínez-Escala E; Lloreta J; Puig S; Vélez M; Pujol RM; Herrero-González JE
    Arch Dermatol; 2010 Sep; 146(9):1021-5. PubMed ID: 20855704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A double-blind controlled study of the efficacy and side effects of thioridazine and chlorpromazine in schizophrenia].
    Guo GY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):300-2, 319-20. PubMed ID: 3234163
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of long-term therapy with aminazin on the structure and function of the liver].
    Avrutskiĭ GIa; Gurovich IIa; Romanov IuD; Khmelevskiĭ DL; Mukhin AS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(7):1050-5. PubMed ID: 5077762
    [No Abstract]   [Full Text] [Related]  

  • 47. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
    Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
    J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
    [No Abstract]   [Full Text] [Related]  

  • 48. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: report of three cases.
    Zhao X; Shi R; Jin X; Zheng J
    J Am Acad Dermatol; 2011 Aug; 65(2):430-432. PubMed ID: 21763571
    [No Abstract]   [Full Text] [Related]  

  • 50. Double-blind comparison of clozapine with chlorpromazine in acute schizophrenic illness.
    Chiu E; Burrows G; Stevenson J
    Aust N Z J Psychiatry; 1976 Dec; 10(4):343-7. PubMed ID: 798582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
    Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ultrastructural study of corneal thickening in the course of chlorpromazine treatment].
    Pouliquen Y; Graf B; Bisson J; Feuvrier YM; Delattre A
    Arch Ophtalmol Rev Gen Ophtalmol; 1970 Nov; 30(11):769-82. PubMed ID: 4250388
    [No Abstract]   [Full Text] [Related]  

  • 53. Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST.
    Alexandrescu DT; Dasanu CA; Farzanmehr H; Kauffman L
    Dermatol Online J; 2008 Jul; 14(7):7. PubMed ID: 18718191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induced corneal opacities in the rat.
    Fabian RJ; Bond JM; Drobeck HP
    Br J Ophthalmol; 1967 Feb; 51(2):124-9. PubMed ID: 6018903
    [No Abstract]   [Full Text] [Related]  

  • 55. Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study.
    Gelenberg AJ; Doller JC
    J Clin Psychiatry; 1979 May; 40(5):238-40. PubMed ID: 374401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cutaneous hyperpigmentation due to chronic quinine ingestion.
    Rosen T; Aponte C
    Cutis; 2005 Feb; 75(2):114-6. PubMed ID: 15773532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Irregular pigmented lesion on the oral mucosa.
    Morganroth PA; Jackson D; Chaffins M
    JAMA Dermatol; 2014 May; 150(5):563-4. PubMed ID: 24599303
    [No Abstract]   [Full Text] [Related]  

  • 58. Long term evolution of the side-effect lens opacities induced by chlorpromazine prolonged therapy.
    Baron JB; Rivoalan Y; Morel P
    Agressologie; 1971; 12(1):57-60. PubMed ID: 5088348
    [No Abstract]   [Full Text] [Related]  

  • 59. Schizophrenia: an illness of distorted reality.
    Dean B
    Biologist (London); 2000 Sep; 47(4):202-6. PubMed ID: 11153121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of two antipsychotic drugs: chlorpromazine and clozapine (author's transl)].
    Dick P; Rémy M; Rey-Bellet JJ
    Ther Umsch; 1975 Aug; 32(8):497-500. PubMed ID: 1099714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.